Aurobac Therapeutics is a startup based in Germany, 1 tracked investor.
Aurobac Therapeutics is a company headquartered in Germany. Brouky records 1 investor associated with the company.
Aurobac Therapeutics is developing innovative therapeutics focused on treating bacterial infections by targeting resistance mechanisms to help combat antibiotic-resistant pathogens.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.